Find the presentations from the event speakers here in PDF format. Click on the orange arrows to download.
Historical Perspective of Medical Products of Human Origin (MPHO)
Dr. Luc Noël, Advisor, MPHO
PLENARY SESSION 2: Traceability Challenges
Chairs: Prof. Dr. Jeremy Chapman and Dr. Ruth Warwick
The Overarching Traceability Needs for MPHO
Dr. Axel Rahmel, German Organ Transplant Foundation (DSO)
The Challenge of Ensuring MPHO Traceability Across Multiple Professional Spheres of Activity
Dr Aurora Vassanelli, Italian National Transplant Centre (CNT)
FDA's Regulatory Framework for Ensuring Traceability of Blood and Blood Components
Dr. Wendy Paul, US Food and Drug Administration (FDA)
PLENARY SESSION 3: Implications of Unregulated Activities for Patient Safety
Chairs: Dr. Ineke Slaper-Cortenbach and Dr. Ziggy Szczepiorkowski
Overview of MPHO Patient Safety in Regulated as well as in Unregulated Environments
Prof. Dr. Jeremy Chapman, Medicine and Cancer at Westmead Hospital, Australia
Unproven Therapies and Patient Safety
Dr. Mickey Koh, WBMT Graft Processing and Cellular Therapy Committee/ISCT task force
Patient Safety, Ethics, and Approvals in CAR T Cell Therapy
Dr. Bruce Levine, President-Elect International Society for Cell and Gene Therapy (ISCT)
PLENARY SESSION 5: Celebration of the 25th Anniversary of ICCBBA: Ensuring Transparency on a Global Basis
Chairs: Mrs. Diane Wilson and Mr. Paul Ashford
One World Award Speech: Continental Unite – Past and Future Traceability of Substances of Human Origin
Ms. Suzanne Butch and Dr. Jørgen Georgsen
PLENARY SESSION 6: Scientific and Ethical Practice: Future Challenges
Chairs: Prof. Dr. Martin Hildebrandt and Dr. Kelly Tilleman
What are the Current Challenges of the Ethical Use of MPHO?
Dr. José Nunez, World Health Organization - Geneva
Genetic Manipulation in Human Reproduction: What are the Challenges?
Dr. Ewa Bartnik, WHO expert advisory group on developing global standards for governance and oversight of Human genome editing
PLENARY SESSION 7: Vigilance and Surveillance of MPHO – the Notify Project and Other International Initiatives
Chairs: Prof. Timothy Pruett and Dr. Salwa Hindawi
EU Strategies for the Vigilance and Surveillance of Substances of Human Origin
Dr. Deirdre Fehily, Directorate-General for Health and Food Safety, European Commission (DG SANTE)
Monitoring the Occurrence of Adverse Events Associated with the Use of Medical Products of Human Origin in the U.S.
Dr. Jefferson Jones, US Centers for Disease Control and Prevention (CDC)
How the NOTIFY Project can Improve the Safety of Transfusion/Transplantation/Application of MPHO.
Dr. Aurora Navarro Cantullera, The Catalan Transplant Organization (OCATT)
PLENARY SESSION 9: Healthcare Informatics and the Role of New Technologies
Chairs: Prof. Dr. Martin Hildebrandt and Dr. Jørgen Georgsen
Cloud, Block Chain and Related Technologies: MPHO Impacts and Opportunities
Mr. Wayne Bolton, Australian Red Cross Blood Service and chair of ICCBBA, TAG-Information Technology Committee
Ethical Aspects of Artificial Intelligence in Medicine
Dr. Stuart McLennan, Technical University Munich, Germany
Photography from Forum 25 is now available in the gallery below. Click on the thumbnails to view photos and to download the photos, click on the orange arrows.